We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$2.04B
AUM Growth
+$132M
Cap. Flow
+$57.2M
Cap. Flow %
2.81%
Top 10 Hldgs %
16.02%
Holding
802
New
92
Increased
355
Reduced
281
Closed
60
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
76
Chevron
CVX
$382B
$6.85M 0.34%
58,406
+3,922
+7% +$446K
NXP icon
77
Nuveen Select Tax-Free Income Portfolio
NXP
$895M
$6.77M 0.33%
+423,381
New +$6.99M
MYOV
78
DELISTED
Myovant Sciences Ltd.
MYOV
$6.76M 0.33%
434,374
+9,172
+2% +$175K
FPF
79
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
$6.73M 0.33%
274,219
-22,195
-7% -$553K
LOW icon
80
Lowe's Companies
LOW
$123B
$6.7M 0.33%
25,936
-4,469
-15% -$1.06M
NEE icon
81
NextEra Energy
NEE
$177B
$6.66M 0.33%
71,305
+3,440
+5% +$297K
ICE icon
82
Intercontinental Exchange
ICE
$84.5B
$6.58M 0.32%
48,085
-7,288
-13% -$965K
ANGL icon
83
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.1B
$6.49M 0.32%
196,752
-309,785
-61% -$10.2M
APLS
84
DELISTED
Apellis Pharmaceuticals
APLS
$6.47M 0.32%
136,760
-45,445
-25% -$1.79M
ISRG icon
85
Intuitive Surgical
ISRG
$139B
$6.46M 0.32%
17,986
+6,319
+54% +$2.17M
TGT icon
86
Target
TGT
$69B
$6.44M 0.32%
27,825
+8,833
+47% +$2.15M
PLYM
87
DELISTED
Plymouth Industrial REIT
PLYM
$6.43M 0.32%
200,964
+9,309
+5% +$258K
SUPN icon
88
Supernus Pharmaceuticals
SUPN
$2.74B
$6.33M 0.31%
217,042
-27,980
-11% -$849K
AUPH icon
89
Aurinia Pharmaceuticals
AUPH
$2.06B
$6.17M 0.3%
270,005
-10,916
-4% -$259K
JNJ icon
90
Johnson & Johnson
JNJ
$631B
$6.13M 0.3%
35,836
+4,861
+16% +$796K
DMF
91
DELISTED
BNY Mellon Municipal Income
DMF
$5.99M 0.29%
684,106
+109,466
+19% +$981K
IQI icon
92
Invesco Quality Municipal Securities
IQI
$533M
$5.98M 0.29%
440,299
+109,833
+33% +$1.45M
ECL icon
93
Ecolab
ECL
$79.7B
$5.98M 0.29%
25,490
-232
-0.9% -$52.4K
MRK icon
94
Merck
MRK
$323B
$5.93M 0.29%
77,343
-6,709
-8% -$534K
HDV
95
iShares Core High Dividend ETF
HDV
$15B
$5.9M 0.29%
292,195
-27,205
-9% -$533K
MDGL icon
96
Madrigal Pharmaceuticals
MDGL
$11.9B
$5.87M 0.29%
69,261
-4,675
-6% -$384K
FAST icon
97
Fastenal
FAST
$59.8B
$5.8M 0.28%
180,984
+7,478
+4% +$220K
NAN icon
98
Nuveen New York Quality Municipal Income Fund
NAN
$373M
$5.71M 0.28%
386,226
+52,567
+16% +$765K
ALL icon
99
Allstate
ALL
$68.2B
$5.63M 0.28%
47,830
+5,121
+12% +$606K
ELV icon
100
Elevance Health
ELV
$86.2B
$5.49M 0.27%
11,839
+4,084
+53% +$1.72M

Similar funds

Hennion & Walsh Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Hennion & Walsh Asset Management held 802 positions worth $2.04B, up 7% from $1.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hennion & Walsh Asset Management's Q4 2021 filing shows 92 new, 355 increased, 281 reduced and 60 closed positions. Its largest new stake was JPMorgan Short Duration Core Plus ETF: 362,975 shares worth $18.1M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $19.1M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Hennion & Walsh Asset Management's largest Q4 2021 buy was JPMorgan Short Duration Core Plus ETF: 362,975 shares worth $18.1M.
  • Hennion & Walsh Asset Management added most to Invesco Value Municipal Income Trust in Q4 2021, an estimated $5M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2021 reduction was BlackRock Municipal Income Trust II, cutting an estimated $10.3M.
  • Hennion & Walsh Asset Management fully exited JPMorgan Ultra-Short Income ETF in Q4 2021, selling an estimated $19.1M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 16% of its $2.04B portfolio in Q4 2021.
  • Hennion & Walsh Asset Management opened 92 new positions and closed 60 in Q4 2021.
  • Hennion & Walsh Asset Management's portfolio value rose 7% quarter-over-quarter to $2.04B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.